Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421237 · ClinicalTrials.gov registry record · NA
Trial of Treatment for Internalized Stigma in Schizophrenia
A NA study, sponsored by John Jay College of Criminal Justice, City University of New York.
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
NCT02421237 is a NA study that has completed, run by John Jay College of Criminal Justice, City University of New York. The registered enrollment target is 170 participants.
The verdict
NCT02421237, a NA study, has completed, sponsored by John Jay College of Criminal Justice, City University of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
Study Summary
The purpose of the present study is to build upon the investigators' previous exploratory intervention development study by conducting an adequately-powered, randomized controlled trial of the Narrative Enhancement/Cognitive Therapy (NECT) intervention among persons with schizophrenia-spectrum disorders.
Interventions
- BEHAVIORAL Supportive Group Therapy
- BEHAVIORAL Narrative Enhancement and Cognitive Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2013-03 |
| Est. Completion | 2018-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02421237
The ClinicalTrials.gov registry entry for NCT02421237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is John Jay College of Criminal Justice, City University of New York, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Supportive Group Therapy is the first listed.
NCT02421237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02421237 about?
NCT02421237 is a clinical study titled "Trial of Treatment for Internalized Stigma in Schizophrenia". The purpose of the present study is to build upon the investigators' previous exploratory intervention development study by conducting an adequately-powered, randomized controlled trial of the Narrative Enhancement/Cognitive Therapy (NECT) intervention among persons with schizophrenia-spectrum disor...
What is the current status of trial NCT02421237?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2013-03. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT02421237?
The interventions under investigation include: Supportive Group Therapy (BEHAVIORAL), Narrative Enhancement and Cognitive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02421237?
This trial is sponsored by John Jay College of Criminal Justice, City University of New York, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.